Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05498792
Title Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field